Chunling Liu

Furmonertinib (AST2818) versus gefitinib as first-line therapy for Chinese patients with locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer (FURLONG): a multicentre, double-blind, randomised phase 3 study

Yuankai Shi, Gongyan Chen, Xiang Wang et al. · The Lancet Respiratory Medicine · 2022 · 211 citations

Versus Gefitinib, Medicine, Pathology +8

Intravoxel incoherent motion (IVIM) in evaluation of breast lesions: Comparison with conventional DWI

Chunling Liu, Changhong Liang, Zaiyi Liu et al. · European Journal of Radiology · 2013 · 199 citations · Full text

Conventional Dwi, Medical Imaging, Breast Lesions +7

MRI-based Quantification of Intratumoral Heterogeneity for Predicting Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer

Zhenwei Shi, Xiaomei Huang, Ziliang Cheng et al. · Radiology · 2023 · 193 citations · Full text

Preoperative prediction of sentinel lymph node metastasis in breast cancer by radiomic signatures from dynamic contrast‐enhanced MRI

Chunling Liu, Jie Ding, Karl Spuhler et al. · Journal of Magnetic Resonance Imaging · 2018 · 189 citations

Intravoxel incoherent motion MR imaging for breast lesions: comparison and correlation with pharmacokinetic evaluation from dynamic contrast-enhanced MR imaging

Chunling Liu, Kun Wang, Queenie Chan et al. · European Radiology · 2016 · 88 citations

Pharmacokinetic Evaluation, Engineering, Medical Imaging +9